DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Orvepitant
Orvepitant
Compositions for Treating Centrally Mediated
( 12 ) United States Patent
Neurokinin Receptor NK Receptor
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Future Treatments for Depression, Anxiety, Sleep Disorders, Psychosis, and ADHD
Neurokinin-1 Antagonist Orvepitant for EGFRI- Induced
WO 2018/005695 Al O
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0231688 A1
Sanofi-Aventis Needs Successes, Not Failures
Innovative Drugs to Treat Depression: Did Animal Models Fail to Be Predictive Or Did Clinical Trials Fail to Detect Effects?
Review Article Pruritus: Progress Toward Pathogenesis and Treatment
WO 2017/152062 Al 8 September 2017 (08.09.2017) P O P C T
O-Ribose Methyltransferase Nsp16 of SARS-Cov-2
Experimental Medication Treatment Approaches for Depression
Viewed in Ref
G Proteinactivation
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Top View
Table [1]: Definition of Reported Outcomes Study Outcome
Emerging Mechanisms and Treatments for Depression Beyond Ssris and Snris
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Experimental Medication Treatment Approaches for Depression
Neuropeptide Receptor Ligands As Drugs for Psychiatric Diseases: the End of the Beginning?